©The Author(s) 2026.
World J Gastroenterol. Feb 7, 2026; 32(5): 113592
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.113592
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.113592
Figure 2 Diagnostic and therapeutic approaches for hepatocellular carcinoma.
CT: Computed tomography; MRI: Magnetic resonance imaging; cf-DNAs: Cell free DNAs; CTCs: Circulating tumor cells; ctDNA: Circulating tumor DNAs; circRNAs: Circular RNAs; mRNA: Messenger RNA; lncRNAs: Long non-coding RNAs; miRNAs: MicroRNAs; EVs: Extracellular vesicles; IHC: Immunohistochemistry; HE: Hematoxylin and eosin staining; CTLA-4: Cytotoxic T lymphocyte-associated antigen-4; PD-1: Programmed death-1; PD-L1: Programmed death ligand 1; TCR: T cell antigen receptor; MHC I: Major histocompatibility complex class I; CD80: Cluster of differentiation 80. The image materials are sourced from Biorender (https://biorender.com) and The Human Protein Atlas (https://www.proteinatlas.org) (Supplementary material).
- Citation: Chen Y, Zhang Q, Zhang MY. Deep learning techniques for using computed tomography imaging for hepatocellular carcinoma diagnosis, treatment and prognosis. World J Gastroenterol 2026; 32(5): 113592
- URL: https://www.wjgnet.com/1007-9327/full/v32/i5/113592.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i5.113592